Further simulations assuming increased TMDD with the enhanced affinity molecule and for low FAP (bladder cancer) and high FAP (esophagus) indications are available in the Supplementary Material (Supplementary Figure S2). The gene discussed is FAP; the disease is urinary bladder carcinoma.